Research ArticleBasic Science Investigations
Monitoring Therapy Response of Experimental Arthritis with Radiolabeled Tracers Targeting Fibroblasts, Macrophages, or Integrin αvβ3
Samantha Y.A. Terry, Marije I. Koenders, Gerben M. Franssen, Tapan K. Nayak, Anne Freimoser-Grundschober, Christian Klein, Wim J. Oyen, Otto C. Boerman and Peter Laverman
Journal of Nuclear Medicine March 2016, 57 (3) 467-472; DOI: https://doi.org/10.2967/jnumed.115.162628
Samantha Y.A. Terry
1Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
2Department of Imaging Chemistry and Biology, King's College London, London, United Kingdom
Marije I. Koenders
3Department of Experimental Rheumatology, Radboud University Medical Center, Nijmegen, The Netherlands
Gerben M. Franssen
1Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
Tapan K. Nayak
4Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland; and
Anne Freimoser-Grundschober
5Roche Innovation Center Zurich, Zurich, Switzerland
Christian Klein
5Roche Innovation Center Zurich, Zurich, Switzerland
Wim J. Oyen
1Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
Otto C. Boerman
1Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
Peter Laverman
1Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 57, Issue 3
March 1, 2016
Monitoring Therapy Response of Experimental Arthritis with Radiolabeled Tracers Targeting Fibroblasts, Macrophages, or Integrin αvβ3
Samantha Y.A. Terry, Marije I. Koenders, Gerben M. Franssen, Tapan K. Nayak, Anne Freimoser-Grundschober, Christian Klein, Wim J. Oyen, Otto C. Boerman, Peter Laverman
Journal of Nuclear Medicine Mar 2016, 57 (3) 467-472; DOI: 10.2967/jnumed.115.162628
Monitoring Therapy Response of Experimental Arthritis with Radiolabeled Tracers Targeting Fibroblasts, Macrophages, or Integrin αvβ3
Samantha Y.A. Terry, Marije I. Koenders, Gerben M. Franssen, Tapan K. Nayak, Anne Freimoser-Grundschober, Christian Klein, Wim J. Oyen, Otto C. Boerman, Peter Laverman
Journal of Nuclear Medicine Mar 2016, 57 (3) 467-472; DOI: 10.2967/jnumed.115.162628
Jump to section
Related Articles
Cited By...
- Fibroblast Activation Protein-Targeted PET/CT with 68Ga-FAPI for Imaging IgG4-Related Disease: Comparison to 18F-FDG PET/CT
- The Latest Developments in Imaging of Fibroblast Activation Protein
- 18F-FAC PET Selectively Images Liver-Infiltrating CD4 and CD8 T Cells in a Mouse Model of Autoimmune Hepatitis